0.5% Hypromellose Eye Drops 10mL | Artificial Lubricant for Dry Eye Relief

Hypromellose Eye Drops
  • Concentration: 0.5% Hypromellose (5 mg/ml)
  • Volume: 5ml or 10ml per bottle
  • Packaging: Sterile plastic dropper bottle, 1 bottle/box
  • Shelf Life: 24 months (unopened)

Click to add this item to cart.

Product Description

Product Name0.5% Hypromellose Eye Drops 10mL (Hypromellose Ophthalmic Solution)
Specification10mL sterile eye drops containing 0.5% Hypromellose (Hydroxypropyl Methylcellulose)
Dosage FormSterile Ophthalmic Solution (Eye Drops — for topical ocular administration)
Active IngredientHypromellose (Hydroxypropyl Methylcellulose — Ophthalmic Lubricant / Demulcent)
Pharmacological ClassOphthalmic Lubricant / Demulcent (Cellulose Derivative Viscosity Agent)
Route of AdministrationTopical ocular (instilled into the conjunctival sac). Typically 1-2 drops in the affected eye(s) as needed, up to several times daily.
PackagingSterile multi-dose dropper bottle (10mL) with tamper-evident seal
StorageStore at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening.
Shelf Life24 months unopened; discard within 4 weeks of first opening

Product Overview

0.5% Hypromellose Eye Drops is a sterile ophthalmic solution containing 0.5% hypromellose (hydroxypropyl methylcellulose). It is a lubricating eye drop used to relieve the symptoms of dry eye, providing lubrication and moisture to the ocular surface.

0.5% Hypromellose Eye Drops 10mL: What the Published Guidance Says

Fifteen ophthalmic products spanning anti-infective, anti-allergic, anti-inflammatory, antiviral and ocular-surface categories — including the two anti-infectives the WHO Model List names for conjunctivitis and infectious keratitis.

0.5% Hypromellose Eye Drops 10mL is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the Ophthalmic range overview.

  • Trachoma and endophthalmitis have separate recommendations For trachoma the treatment of choice is a single oral dose of azithromycin, with topical azithromycin or tetracycline also indicated. For bacterial endophthalmitis, the listings for ceftazidime, ceftriaxone and vancomycin were extended to cover it as a first-choice option, with the Committee noting that intravitreal administration requires specialist training and adequate infrastructure. WHO eEML — Ofloxacin (ophthalmological)
  • Gentamicin eye drops 0.3% are on the Model List for ocular infection WHO lists gentamicin eye drops 0.3% (gentamicin sulfate) for infectious blepharitis, classified in the Access group of the AWaRe framework. The Expert Committee has specified amikacin, kanamycin, netilmicin and tobramycin as therapeutic alternatives under the gentamicin square-box listing. WHO eEML — Gentamicin (ophthalmological)
  • Evidence for conjunctivitis does not favour one antibiotic over another The Committee noted that topical antibiotics are indicated for moderate to severe infection and can be considered in mild cases, but that available evidence does not make it possible to identify specific, preferred antibiotics for conjunctivitis. It therefore endorsed the existing gentamicin and tetracycline listings rather than picking a winner. WHO eEML — Ofloxacin (ophthalmological)

We quote these sources rather than paraphrase them loosely, because the detail matters commercially for 0.5% Hypromellose Eye Drops 10mL. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.

Supply & Specification Data for 0.5% Hypromellose Eye Drops 10mL

Product Name0.5% Hypromellose Eye Drops 10mL (Hypromellose Ophthalmic Solution)
Specification10mL sterile eye drops containing 0.5% Hypromellose (Hydroxypropyl Methylcellulose)
Dosage FormSterile Ophthalmic Solution (Eye Drops — for topical ocular administration)
Active IngredientHypromellose (Hydroxypropyl Methylcellulose — Ophthalmic Lubricant / Demulcent)
Pharmacological ClassOphthalmic Lubricant / Demulcent (Cellulose Derivative Viscosity Agent)
Route of AdministrationTopical ocular (instilled into the conjunctival sac). Typically 1-2 drops in the affected eye(s) as needed, up to several times daily.
StorageStore at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening.
Therapeutic groupOphthalmic — Ophthalmic
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL, 5% Taurine Eye Drops 10mL, 1% Acyclovir Eye Drops 10mL, 0.5% Chloramphenicol Eye Drops 10mL, 0.3% Gentamicin Eye Drops 10mL, 0.5% Kanamycin Eye Drops 10mL, 2.5% Lincomycin Hydrochloride Eye Drops 10mL, 0.5% Moxifloxacin Hydrochloride Eye Drops 10mL.

Testing, Monographs & Batch Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Every batch of 0.5% Hypromellose Eye Drops 10mL is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

The batch record for this product normally includes:

  • Testing for water content and pH where applicable
  • Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
  • Testing for microbial limits and preservative efficacy (multi-dose presentations)
  • Testing for heavy metals and elemental impurities
  • Testing for packaging integrity and seal testing
  • Testing for description and identification

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Pack Configuration, Artwork & Shipping Documents

  • Pack size: Sterile multi-dose dropper bottle (10mL) with tamper-evident seal. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening..
  • Shelf life: 24 months unopened; discard within 4 weeks of first opening. Stability data for the marketed pack is included in the dossier.
  • Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
  • Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.

Dossier, Authority Filings & Tender Documentation

Documents for 0.5% Hypromellose Eye Drops 10mL are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.

  • Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
  • Batch manufacturing and packaging records released for inspection on request during supplier audits.
  • Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
  • CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
  • Site Master File and GMP certificate for the manufacturing workshops.

The context for 0.5% Hypromellose Eye Drops 10mL is its place among ophthalmic preparations used in WHO and MSF eye-care protocols. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.

Buyer Questions about 0.5% Hypromellose Eye Drops 10mL

What pack size is available for 0.5% Hypromellose Eye Drops 10mL?

This presentation is normally supplied as Sterile multi-dose dropper bottle (10mL) with tamper-evident seal. Where your market requires a different count, bottle or carton, we quote to your artwork and extend the stability file to the new pack.

What documentation comes with a shipment of 0.5% Hypromellose Eye Drops 10mL?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 24 months unopened; discard within 4 weeks of first opening.

Does the batch documentation for 0.5% Hypromellose Eye Drops 10mL support a registration filing?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 24 months unopened; discard within 4 weeks of first opening. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Do you supply preservative-free eye drops?

We can supply both preserved and preservative-free presentations depending on the product and your market requirement. Specify the preservative system on your enquiry.

Can you supply trypan blue for cataract surgery?

Yes. Trypan blue ophthalmic solution is available for capsule staining, supplied with sterility documentation.

Other Ophthalmic Products in This Range

Browse the full Ophthalmic range; all Ophthalmic; the complete product catalogue.

Request a Quotation for 0.5% Hypromellose Eye Drops 10mL

For tenders and programme supply, send the line item, pack size, quantity and destination for 0.5% Hypromellose Eye Drops 10mL 10mL. We return a quotation with lead time, documentation list and sample availability in one response.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products